1.
Daly/Cost comparison in the management of peripheral arterial disease at 17 Belgian hospitals.
2.
Prospective, real-time monitoring of Pegylated E.coli and Erwinia asparaginase therapy in childhood acute lymphoblastic leukemia and Non-Hodgkin lymphoma in Belgium
3.
4.
Prospective, real-time monitoring of pegylated Escherichia coli and Erwinia asparaginase therapy in childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma in Belgium